Angela Delaney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angela Delaney has a total of 357 co-authors. Here are the top co-authors by number of shared publications:
- Melissa M. Hudson
Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA
49 shared publications - Kirsten K. Ness
Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, USA
46 shared publications - Matthew J. Ehrhardt
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
44 shared publications - Deo Kumar Srivastava
Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, USA
43 shared publications - Leslie L. Robison
Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
43 shared publications - Tara M. Brinkman
Department of Psychology and Biobehavioral Sciences St. Jude Children's Research Hospital Memphis Tennessee USA
42 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 101, 104255
Neighborhood disadvantages and longitudinal progression of multimorbidity among adult survivors of childhood cancer: a single-center St. Jude Lifetime Cohort Study in the U.S.
- 13 October 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 101, 104255
Open AccessNeighborhood disadvantages and longitudinal progression of multimorbidity among adult survivors of childhood cancer: a single-center St. Jude Lifetime Cohort Study in the U.S.
- Open Access
Sex Differences in Human Subcortical Anatomy are Robust and Replicable in Adulthood, Already Evident Prepubertally, and Aligned with Sex Chromosomal and Gonadal Influences
The existence and mechanistic bases of sex effects on human subcortical anatomy remain unclear. To address these gaps, we combined structural neuroimaging of sex differences in subcortical volume and shape across three independent cohorts (combined N=2,886) with neuroimaging maps of sex chromosomal and endocrine effects from three clinical cohorts (combined N=313, including sex chromosome aneuploidies and isolated gonadotropin-releasing hormone deficiency). We found that human subcortical anatomy shows focal sex differences of moderate-strong effect size during young adulthood (male-biased surface area overlying lateral/ventral putamen and pallidum, nucleus accumbens, ventral posterior complex of thalamus, anterior hippocampus, and medial and central nuclei of amygdala; female-biased surface area overlying caudate head, posterior/dorsal pallidum, mediodorsal, lateral dorsal, lateral geniculate, and medial geniculate nuclei of thalamus, posterior hippocampus, and basolateral and lateral nuclei of amygdala). These regional sex differences show strong within-sample reproducibility at modest sample sizes (N≥200) and are replicable in a fully independent mid-adulthood cohort. Strikingly, we find that the topography of adult subcortical sex differences is already established by pre/early puberty (age 9 years), and the same holds for cortical sex differences. Comparison with neuroimaging data from rare disorder cohorts reveals that subcortical sex differences show a statistically significant spatial and directional congruence with the anatomical effects of X-chromosome dosage in the striatum and effects of testicular hormones in the amygdala. Together, these findings provide a reference map for the fine-grained spatial patterning of sex differences in adult subcortical shape, demonstrating its replicability, establishment before pubertal progression, and spatial concordance with potentially causal sex chromosomal and gonadal effects.
Open AccessSex Differences in Human Subcortical Anatomy are Robust and Replicable in Adulthood, Already Evident Prepubertally, and Aligned with Sex Chromosomal and Gonadal Influences
The existence and mechanistic bases of sex effects on human subcortical anatomy remain unclear. To address these gaps, we combined structural neuroimaging of sex differences in subcortical volume and shape across three independent cohorts (combined N=2,886) with neuroimaging maps of sex chromosomal and endocrine effects from three clinical cohorts (combined N=313, including sex chromosome aneuploidies and isolated gonadotropin-releasing hormone deficiency). We found that human subcortical anatomy shows focal sex differences of moderate-strong effect size during young adulthood (male-biased surface area overlying lateral/ventral putamen and pallidum, nucleus accumbens, ventral posterior complex of thalamus, anterior hippocampus, and medial and central nuclei of amygdala; female-biased surface area overlying caudate head, posterior/dorsal pallidum, mediodorsal, lateral dorsal, lateral geniculate, and medial geniculate nuclei of thalamus, posterior hippocampus, and basolateral and lateral nuclei of amygdala). These regional sex differences show strong within-sample reproducibility at modest sample sizes (N≥200) and are replicable in a fully independent mid-adulthood cohort. Strikingly, we find that the topography of adult subcortical sex differences is already established by pre/early puberty (age 9 years), and the same holds for cortical sex differences. Comparison with neuroimaging data from rare disorder cohorts reveals that subcortical sex differences show a statistically significant spatial and directional congruence with the anatomical effects of X-chromosome dosage in the striatum and effects of testicular hormones in the amygdala. Together, these findings provide a reference map for the fine-grained spatial patterning of sex differences in adult subcortical shape, demonstrating its replicability, establishment before pubertal progression, and spatial concordance with potentially causal sex chromosomal and gonadal effects.
- Open Access
- 30 September 2026
- Published by American Society of Hematology in Blood Advances
Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study
Survivors of childhood cancer are at risk of adverse sequelae related to prior therapies. We describe the prevalence of and risk factors for late (≥5 years from cancer diagnosis) venous thromboembolism (VTE) among participants of the St. Jude Lifetime Cohort (N=5229). Prevalence of late VTE was compared between survivors and community controls (N=737) without a history of childhood cancer. Associations with treatment and clinical factors were assessed in multivariable regression models. Ninety-four (1.8% 95% CI 1.5-2.2%) survivors [median age at cancer diagnosis 9.4 years (range:0.0-20.9); 38.5 years (12-65.9) at evaluation] had 108 VTEs vs. 5 (0.7% 95% CI 0.2%-1.6%) among controls (p=0.02) (31.1 years [12.1-70.2] at evaluation). The cumulative incidence 35 years from diagnosis was highest among survivors of Hodgkin lymphoma (7.6% [95% CI 4.5%-11.8%]). Fifty-eight of 108 (53.7%) were in an extremity (upper=7, lower=51) followed by pulmonary (38, 35.2%), abdomen (n=5, 4.6%), neck (n=3, 2.8%), cerebral sinus (n=1, 0.9%), other (n=3, 2.8%). No associations with early (<5 years from cancer diagnosis) VTE were identified (p=0.7). In adjusted models, late VTE was associated with exposure to chest (OR 2.0 95% CI 1.01-4.0) and abdominal (OR 2.2 95% CI 1.04-4.8) radiation, not combined radiation fields (OR 1.2 95% CI 0.7-2.0), and sex hormone use (OR 2.2 95% CI 1.2-3.7). The prevalence of and risk for VTE are elevated among survivors of childhood cancer, particularly those treated with radiation or using sex hormones. Incorporating these factors into risk assessments may guide monitoring, prophylaxis, or interventions, particularly in high-risk situations.
- 30 September 2026
- Published by American Society of Hematology in Blood Advances
Open AccessLate Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study
Survivors of childhood cancer are at risk of adverse sequelae related to prior therapies. We describe the prevalence of and risk factors for late (≥5 years from cancer diagnosis) venous thromboembolism (VTE) among participants of the St. Jude Lifetime Cohort (N=5229). Prevalence of late VTE was compared between survivors and community controls (N=737) without a history of childhood cancer. Associations with treatment and clinical factors were assessed in multivariable regression models. Ninety-four (1.8% 95% CI 1.5-2.2%) survivors [median age at cancer diagnosis 9.4 years (range:0.0-20.9); 38.5 years (12-65.9) at evaluation] had 108 VTEs vs. 5 (0.7% 95% CI 0.2%-1.6%) among controls (p=0.02) (31.1 years [12.1-70.2] at evaluation). The cumulative incidence 35 years from diagnosis was highest among survivors of Hodgkin lymphoma (7.6% [95% CI 4.5%-11.8%]). Fifty-eight of 108 (53.7%) were in an extremity (upper=7, lower=51) followed by pulmonary (38, 35.2%), abdomen (n=5, 4.6%), neck (n=3, 2.8%), cerebral sinus (n=1, 0.9%), other (n=3, 2.8%). No associations with early (<5 years from cancer diagnosis) VTE were identified (p=0.7). In adjusted models, late VTE was associated with exposure to chest (OR 2.0 95% CI 1.01-4.0) and abdominal (OR 2.2 95% CI 1.04-4.8) radiation, not combined radiation fields (OR 1.2 95% CI 0.7-2.0), and sex hormone use (OR 2.2 95% CI 1.2-3.7). The prevalence of and risk for VTE are elevated among survivors of childhood cancer, particularly those treated with radiation or using sex hormones. Incorporating these factors into risk assessments may guide monitoring, prophylaxis, or interventions, particularly in high-risk situations.
- Open Access
- 13 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Regional sex differences in human cortical anatomy vary in their morphometric bases and overlap with sex chromosomal and gonadal influences
Humans show reproducible sex differences in regional cortical volume (CV), but it remains unclear how these relate to the two biologically dissociable determinants of CV – surface area (SA) and cortical thickness (CT) – or to potentially causal sex chromosomal and gonadal effects. Here, we analyze neuroimaging data in two independent human cohorts ( N = 1754) to identify and interrelate highly reproducible sex differences in regional CV, SA and CT – as well as their alignment with distinct functional networks and histomolecular signatures. Integrating neuroimaging data from clinical cohorts with sex chromosome aneuploidy and isolated gonadotropin-releasing hormone deficiency (N = 313) establishes that regions of sex-biased cortical anatomy are enriched for congruent effects of X-chromosome dosage (e.g., primary sensory and insular cortices) and gonadal hormones (e.g., dorsal parietal regions and angular gyrus). This work refines maps of sex-biased human cortical organization and helps to narrow hypotheses regarding their potential genetic and endocrine causes.
- 13 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessRegional sex differences in human cortical anatomy vary in their morphometric bases and overlap with sex chromosomal and gonadal influences
Humans show reproducible sex differences in regional cortical volume (CV), but it remains unclear how these relate to the two biologically dissociable determinants of CV – surface area (SA) and cortical thickness (CT) – or to potentially causal sex chromosomal and gonadal effects. Here, we analyze neuroimaging data in two independent human cohorts ( N = 1754) to identify and interrelate highly reproducible sex differences in regional CV, SA and CT – as well as their alignment with distinct functional networks and histomolecular signatures. Integrating neuroimaging data from clinical cohorts with sex chromosome aneuploidy and isolated gonadotropin-releasing hormone deficiency (N = 313) establishes that regions of sex-biased cortical anatomy are enriched for congruent effects of X-chromosome dosage (e.g., primary sensory and insular cortices) and gonadal hormones (e.g., dorsal parietal regions and angular gyrus). This work refines maps of sex-biased human cortical organization and helps to narrow hypotheses regarding their potential genetic and endocrine causes.
- Top Cited PapersOpen Access
- 28 May 2026
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 7 (5) , 100851
Pain and frailty progression in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort study
- 28 May 2026
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 7 (5) , 100851
Top Cited PapersOpen AccessPain and frailty progression in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort study
- 25 February 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (8) , e2018-e2029
Hypothalamic-pituitary deficiency after radiation in childhood cancer survivors is associated with rare variants in TNS2
Context: Radiation to the hypothalamic-pituitary (HP) region (HP-RT) is a strong risk factor for HP deficiency among childhood cancer survivors (survivors). However, there is inter-individual variability in developing HP deficiency after similar HP-RT dose exposures. Objectives: To assess the genetic contribution to developing deficiencies of GH (GHD), LH/FSH (LH/FSHD), thyroid-stimulating hormone deficiency (thyroid-stimulating hormone deficiency [TSHD]), and ACTH (adrenocorticotropic hormone deficiency [ACTHD]) among survivors exposed to HP-RT. Methods: Eligible participants included 5-year survivors exposed to HP-RT (n = 809; median follow-up 31.9 years) from the St. Jude Lifetime Cohort. We assessed the association between rare variants from whole-exome sequencing data (minor allele frequency [MAF] < 0.01, predicted to be pathogenic by functional prediction tools) and HP deficiency rate (total counts/person-year) among 801 survivors by the exact Poisson test. Genome-wide association analysis (GWAS) was conducted among 606 survivors of European ancestry with available whole-genome sequence data, targeting variants with MAF ≥ 0.01. The replication population was 1328 survivors from the Childhood Cancer Survivor Study (CCSS). Results: Carriers of rare variants in TNS2, a ubiquitously expressed protein-coding gene including in brain, had significantly higher rates of HP deficiencies (rate ratio 2.72 [95% CI 1.81-4.09], P = 1.5 × 10−5) compared to non-carriers, which was replicated in the CCSS. This was also observed in individual HP deficiencies: LH/FSHD (3.31 [1.28-7.99]), TSHD (5.29 [2.42-11.34]), and ACTHD (3.97 [1.05-12.31]). There were no statistically significant variants in GWAS. Conclusion: TNS2 may contribute to radiation-induced HP deficiencies. With further validation, screening for TNS2 variants has potential to help identify individuals who would benefit from surveillance and intervention following HP-RT.
- 25 February 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (8) , e2018-e2029
Hypothalamic-pituitary deficiency after radiation in childhood cancer survivors is associated with rare variants in TNS2
Context: Radiation to the hypothalamic-pituitary (HP) region (HP-RT) is a strong risk factor for HP deficiency among childhood cancer survivors (survivors). However, there is inter-individual variability in developing HP deficiency after similar HP-RT dose exposures. Objectives: To assess the genetic contribution to developing deficiencies of GH (GHD), LH/FSH (LH/FSHD), thyroid-stimulating hormone deficiency (thyroid-stimulating hormone deficiency [TSHD]), and ACTH (adrenocorticotropic hormone deficiency [ACTHD]) among survivors exposed to HP-RT. Methods: Eligible participants included 5-year survivors exposed to HP-RT (n = 809; median follow-up 31.9 years) from the St. Jude Lifetime Cohort. We assessed the association between rare variants from whole-exome sequencing data (minor allele frequency [MAF] < 0.01, predicted to be pathogenic by functional prediction tools) and HP deficiency rate (total counts/person-year) among 801 survivors by the exact Poisson test. Genome-wide association analysis (GWAS) was conducted among 606 survivors of European ancestry with available whole-genome sequence data, targeting variants with MAF ≥ 0.01. The replication population was 1328 survivors from the Childhood Cancer Survivor Study (CCSS). Results: Carriers of rare variants in TNS2, a ubiquitously expressed protein-coding gene including in brain, had significantly higher rates of HP deficiencies (rate ratio 2.72 [95% CI 1.81-4.09], P = 1.5 × 10−5) compared to non-carriers, which was replicated in the CCSS. This was also observed in individual HP deficiencies: LH/FSHD (3.31 [1.28-7.99]), TSHD (5.29 [2.42-11.34]), and ACTHD (3.97 [1.05-12.31]). There were no statistically significant variants in GWAS. Conclusion: TNS2 may contribute to radiation-induced HP deficiencies. With further validation, screening for TNS2 variants has potential to help identify individuals who would benefit from surveillance and intervention following HP-RT.
Insights into the role of chemotherapy and thyroid peroxidase antibodies in risk for primary hypothyroidism among childhood cancer survivors
A new study has found that chemotherapy does not increase risk for primary hypothyroidism, but that cisplatin increases this risk in combination with radiation therapy in childhood cancer survivors. This and other findings, including the prevalence of thyroid peroxidase antibodies among survivors, are discussed in the context of previous studies and suggestions for future research.
Insights into the role of chemotherapy and thyroid peroxidase antibodies in risk for primary hypothyroidism among childhood cancer survivors
A new study has found that chemotherapy does not increase risk for primary hypothyroidism, but that cisplatin increases this risk in combination with radiation therapy in childhood cancer survivors. This and other findings, including the prevalence of thyroid peroxidase antibodies among survivors, are discussed in the context of previous studies and suggestions for future research.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Supplementary Table S1 shows the differences in frailty status breakdowns for the SJLIFE community control cohort versus our study participants (N=3806)
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Supplementary Table S1 shows the differences in frailty status breakdowns for the SJLIFE community control cohort versus our study participants (N=3806)
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Supplementary Table S3 shows comparisons of pre-frailty/frailty odds between weighted and unweighted models, completed to evaluate for potential participation bias
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Supplementary Table S3 shows comparisons of pre-frailty/frailty odds between weighted and unweighted models, completed to evaluate for potential participation bias
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Supplementary Table S2 shows the results of bivariate analyses between individual-level participant variables and frailty status
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Supplementary Table S2 shows the results of bivariate analyses between individual-level participant variables and frailty status